The FDA has found that their first analysis of the Coronavirus Vaccine has worked well for everyone no matter race, weight, or age. In December of 2020 FDA officials in Washington DC have concluded the vaccine made by Pfizer and BioNTech provides strong protection against Covid after the first dose. 

Several companies have been working on the vaccine for a while now, however the company Pfizer has been the quickest and most promising so far. They announced that protection for the vaccine starts kicking in far earlier than expected. 

“Last month, Pfizer and BioNTech announced that their two-dose vaccine had an efficacy rate of 95 percent after two doses administered three weeks apart. The new analyses show that the protection starts kicking in far earlier.”

Pfizer and BioNTech actually did a large-scale clinical trial in July with over 44,000 people from various countries. Half of them were given the vaccine and the other half were given a placebo. Cases decreased and soon disappeared and the vaccinated group within 10 days, while they still increased in the placebo group. 

“New coronavirus cases quickly tapered off in the vaccinated group of volunteers about 10 days after the first dose, according to one graph in the briefing materials. In the placebo group, cases kept steadily increasing.”

As numbers only continue to heavily increase and US Covid numbers are at an all time high, it would make sense to start getting the vaccine dispersed as soon as possible. The smart idea would be to get it out to people at higher risk and health care workers first, to stabilize that situation then slowly make it accessible to everyone else.